VAISHALI PHARMA
|
The Current P/S Ratio of VAISHALI PHARMA is 0.70.
| Share Price | ₹6.1 | Mar 13,2026 |
| Market Cap | ₹79.9 Cr | |
| Sales-TTM | ₹114.1 Cr | TTM-Standalone Results |
| Price/Sales | 0.70x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of VAISHALI PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹79.9 Cr] as on Mar 13,2026
(/) Sales [ ₹114.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 0.70x ]
Thus, for VAISHALI PHARMA , the investors are currently willing to pay '0.70 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of VAISHALI PHARMA !
The chart below summarizes the trend in P/S Ratio of VAISHALI PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of VAISHALI PHARMA
PS Ratio Performance Analysis for VAISHALI PHARMA
- VAISHALI PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.43x.
- VAISHALI PHARMA 's operated at median p/e ratio of 1.66x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VAISHALI PHARMA 's p/e ratio peaked in Mar2023 at 2.21x.
- VAISHALI PHARMA 's p/e ratio hit its five-year low in Mar2021 of 0.64x.
How does VAISHALI PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| VAISHALI PHARMA | 114.1 | 0.70 | 79.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.60 | 432,000.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.62 | 161,076.0 |
| CIPLA LTD | 28,351.1 | 3.74 | 106,150.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.66 | 148,510.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.11 | 107,921.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.34 | 88,243.3 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.49 | 91,164.8 |
| LUPIN LTD | 26,150.5 | 4.05 | 105,799.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.27 | 75,283.5 |
| ABBOTT INDIA LTD | 6,824.1 | 8.38 | 57,194.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs VAISHALI PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 0.70x |
| Max industry PS | 15.62x |
| Median industry PS | 4.05x |
| Average industry PS | 6.09x |
You may also like the below Video Courses